Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 26 Mar 2024 for Cumberland Pharmaceuticals INC, €1,976. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
James L. Herman: trading record in brief
This profile gathers the share dealings of James L. Herman in Cumberland Pharmaceuticals Inc. Between 17 March 2021 and 23 March 2024, the trades on record add up to 4 filings.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 26 March 2024 came the latest disclosure, a share grant for €1,976 in Cumberland Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 22 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to James L. Herman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
1,186 shares@ US$1.819.3% of flowCommon StockSEC:0001214659-24-005215:0
1,280 shares@ US$1.9210.9% of flowCommon StockSEC:0001209191-23-020346:0
1,280 shares@ US$2.7422.0% of flowCommon StockSEC:0001209191-22-026142:0
2,560 shares@ US$3.2248.2% of flowCommon StockSEC:0001209191-21-039926:0
4 of 4 declarations
